SydLab One is the first all-in-one laboratory platform capable of performing end-to-end bioassays and high-content screening of drugs and chemicals on micro-organisms in a fully automated and standardized way. Engineered by EPFL spin-off Nagi Bioscience, the technology is now available in the market.
Nagi is a Switzerland-based medical technology company that develops laboratory equipment and organism-on-a-chip products for sectors including biopharma and agrochemicals.